Gainers
- MoonLake MLTX shares rose 18.8% to $62.5 during Monday's after-market session. Today's trading volume for this security ended up closing at 260.5K shares, which is 35.3 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $3.3 billion.
- Renalytix RNLX stock moved upwards by 14.86% to $2.55. The company's market cap stands at $121.1 million.
- Jasper Therapeutics JSPR shares rose 9.06% to $0.84. The company's market cap stands at $93.0 million.
- Virpax Pharmaceuticals VRPX stock moved upwards by 7.87% to $0.85. The market value of their outstanding shares is at $9.9 million.
- Biophytis BPTS stock moved upwards by 7.69% to $1.54. The market value of their outstanding shares is at $8.2 million.
- MSP Recovery LIFW shares increased by 7.62% to $0.06. This security traded at a volume of 167.8K shares come close, making up 15.8% of its average volume over the last 100 days. The company's market cap stands at $21.5 million.
Losers
- Sight Sciences SGHT shares decreased by 25.0% to $4.88 during Monday's after-market session. The market value of their outstanding shares is at $237.4 million.
- Elutia ELUT shares declined by 11.91% to $1.11. The company's market cap stands at $18.0 million.
- Nemaura Medical NMRD stock fell 8.13% to $0.37. The market value of their outstanding shares is at $10.6 million.
- Catheter Precision VTAK stock decreased by 7.02% to $0.53. The company's market cap stands at $3.4 million.
- Aptevo Therapeutics APVO shares fell 6.85% to $0.35. The company's market cap stands at $4.0 million.
- Amphastar Pharma AMPH stock declined by 6.57% to $48.0. The market value of their outstanding shares is at $2.3 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in